Page 314 - Effectiveness News Today

Following EMA’s interim recommendations to support national authorities who may decide on early use of Lagevrio (molnupiravir) prior to marketing...

>> yeah, like you said well hear more specifically about omicron and the effectiveness of these vaccines. but delta is still the biggest concern. so we do get -- we do have some data from moderna specifically about delta. looking at hospitalizations, looking at infections. well separate those out. and look, against hospital admission, what the vaccines are really designed to do to prevent severe illness, it remains effective against delta. that data holds up. what a lot of people are paying atte...

But, you know, one year on todays news, actually does have its own nice bright spot in it. today pfizer released more clinical trial data on its anti-viral pill. this is a treatment that you can take if you get infected with covid-19. this is phase two and three clinical study data that shows the pill is like earlier studies show, its 89% effective at keeping high risk people who catch covid-19 alive and out of the hospital. more than 2,000 unvaccinated study participants, nobody who received pf...

Has been anticipated. we saw evidence of that in europe as well. so this should not be a surprise and its pretty more clearly more contagious. in terms of severity. one question is, look at the total number of cases and determine what proportion of those people are getting severely ill, needing to be hospitalized. and there, the news appears to be better. early days, but if you look overall at the data, the proportion of people who end up in the hospital with omicron versus with previous variant...

Familys life. >> reporter: bowling green never expected to experience anything like this, but experts say as these storms become more frequent, more and more communities are going to have to make plans to keep themselves safe lester >> dasha burns, thank you. now to the pandemic, and good news from pfizer today about the effectiveness of its covid pill but it could still be weeks away from authorization, and it comes as infections and hospitalizations soar to alarming levels heres miguel almag...

Measured in weeks. however, when you get the booster which is in the red circles for omicron, it increases to 75% effectiveness against symptomatic disease with a booster dose. so what does all of this tell us very clearly and very emphatically? last slide. the omicron variant undoubtedly compromises the effects of a two-dose mrna vaccine-induced antibodies and reduces the overall protection. however, as i showed on a prior slide, considerable protection still maintains against severe disease. t...

In south east asia. just 2.4% of the population has recieved two doses of the jab. one expert raising concerns is adrian prouse is head of international humanitarian programs at the australian he explained by the current rates of vaccination are so low. �* , ., rates of vaccination are so low. �* , ., , ., rates of vaccination are so low. �*, ., , ., ., low. its no different to what we are seeing _ low. its no different to what we are seeing across - low. its no different to what we are s...

Vaccination rate of any country in south east asia. just 2.1t% of the population has received two doses of the jab. adrian prouse is head of international humanitarian programmes at the australian red cross. he explained why the current rates of vaccination are so low. there is been recent research done and it gives us the best indicator where it talks about and it is no different to what were seeing the world in terms of two main issues that keep coming up which is people are concerned about si...

Effectiveness of a two-dose pfizer vaccine against the omicron variant. on the left hand part, as has been reported in multiple other studies, the effectiveness against the co-v-2 infection is down from 80% from the preomicron variant, but note on the right-hand part of the slide that the effectiveness against hospitalization, which is critical, still maintains a 70% effectiveness. obviously this is significantly down, but there is the maintaining of a degree of protection against hospitalizatio...

Covid-19. this is phase two and three clinical study data that shows the pill is like earlier studies show, its 89% effective at keeping high risk people who catch covid-19 alive and out of the hospital. more than 2,000 unvaccinated study participants, no one that received the anti-viral pill died. and you do need people to get this pill pretty soon after they start having symptoms. if you take the pill within five days instead of three days, the pills effectiveness starts to drop. but it is sti...